The Board of Directors of Neuland Laboratories Ltd (NEULANDLAB) at its meeting held on 11 May 2021, has declared Final Dividend of Rs 3 per equity share. The meeting of Board of Directors of the Company commenced at 12:15 P.M. and concluded at 02:35 P.M.
Neuland Laboratories Ltd Q4 Result
The company reported 27.69% yoy increase in consolidated sales revenues for the Mar-21 quarter at Rs 244.71 cr. Further, the net profit in the Mar-21 quarter turned around to profit of Rs 17.29 cr as against a net loss of Rs -9.3 cr in Mar-20 quarter.
Similar Posts
- Balkrishna Industries Ltd Declares Final Dividend of Rs 5
- Mrs. Bectors Food Specialities Ltd Declares Final Dividend of Rs 2.4
Neuland Laboratories Ltd Dividend Record Date
The company in its letter has informed the exchanges that it has fixed 30 June 2021 as the Record date. Payment of dividend will be made to those shareholders whose names appear as Beneficial Owners as at the close of business hours on Wednesday, i.e. 30 June 2021.
Moreover, to receive dividend, you must have shares in your demat account on record date. Hence, you should buy shares before ex-dividend date. Note – If you buy shares on ex-dividend date, you will not be eligible to receive dividend. Bookmark our website for latest and upcoming dividend announced by companies in 2021.
Above all, here is the copy of statement, the company has sent to the exchanges:
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations a Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations, 2015”), we wish to inform you that the Board of Directors at their meeting held on even date have recommended payment of final dividend of Rs. 3/-(30%) per equity share on a face value of Rs. 10 each.
Important Dates
- Company – Neuland Laboratories Ltd
- Script Name – NEULANDLAB (NSE) and 524558 (BSE)
- Dividend Amount – 3 Rs Per Share
- Dividend Type – Final
- Ex-Dividend Date – 29 June 2021
- Record Date – 30 June 2021
- Payment Date – August 3, 2021
Also, you can find more information about Neuland Laboratories Ltd on National Stock Exchange and Moneycontrol – Neuland Laboratories Ltd is engaged in the manufacture of a range of bulk pharmaceutical chemicals and intermediates in the therapeutic categories like anti-asthmatics, anti-bacterials (fluoroquinolones), anti-ulcerants and cardiovascualrs.